Trial site
New Zealand Clinical Research
Auckland, 1010, New ZealandNot linked to an institution yet
- 8running trials
- 7closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Phase
- Phase 18 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 32 trials
- Status
- Completed6 trials
- Recruiting5 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Assembly Biosciences3 trials
- Janssen Research & Development, LLC3 trials
- Precision BioSciences, Inc.2 trials
- Dr. Reddy's Laboratories Limited, India1 trial
- IntegerBio1 trial
- and 5 more
Running trials
Not yet recruiting
A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants
NCT07744828· Phase 1· Dr. Reddy's Laboratories Limited, India· Source
Contact: Naveen Reddy
Recruiting
A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
NCT07389044· Phase 1· IntegerBio· Source
Contact: Edward Gane, MBChB, MD
Enrolling by invitation
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
NCT07254208· Precision BioSciences, Inc.· Source
Recruiting
A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
NCT07200193· Phase 1/2· nChroma Bio· Source
Contact: Edward Gane
Recruiting
Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
NCT06671093· Phase 1· Tune Therapeutics, Inc.· Source
Contact: New Zealand Clinical Research
Recruiting
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
NCT06680232· Phase 1· Precision BioSciences, Inc.· Source
Contact: Edward Gane, MD
Recruiting
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
NCT06128629· Phase 3· Intellia Therapeutics· Source
Contact: Trial Manager at Intellia
Active, not recruiting
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
NCT05681351· Phase 3· Ionis Pharmaceuticals, Inc.· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Terminated
A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110
NCT06677307· Phase 1/2· Korro Bio, Inc.· Source
Completed
A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes
NCT06698575· Phase 1· Assembly Biosciences· Source
Completed
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
NCT06384131· Phase 1· Assembly Biosciences· Source
Completed
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes
NCT06385327· Phase 1· Assembly Biosciences· Source
Completed
A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection
NCT05123599· Phase 1· Janssen Research & Development, LLC· Source
Completed
A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection
NCT04585789· Phase 2· Janssen Research & Development, LLC· Source
Completed
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
NCT04535544· Phase 2· Janssen Research & Development, LLC· Source
Report an error